Cargando…

Highly Expressed Integrin-α8 Induces Epithelial to Mesenchymal Transition-Like Features in Multiple Myeloma with Early Relapse

Despite recent groundbreaking advances in multiple myeloma (MM) treatment, most MM patients ultimately experience relapse, and the relapse biology is not entirely understood. To define altered gene expression in MM relapse, gene expression profiles were examined and compared among 16 MM patients gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryu, Jiyeon, Koh, Youngil, Park, Hyejoo, Kim, Dae Yoon, Kim, Dong Chan, Byun, Ja Min, Lee, Hyun Jung, Yoon, Sung-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Molecular and Cellular Biology 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223107/ https://www.ncbi.nlm.nih.gov/pubmed/28008160 http://dx.doi.org/10.14348/molcells.2016.0210

Ejemplares similares

Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant?
por: Park, Hyunkyung, et al.
Publicado: (2020)

Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease
por: Byun, Ja Min, et al.
Publicado: (2022)

P1157: PHASE II STUDY OF GLOFITAMAB, POSELTINIB AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE B CELL LYMPHOMAS
por: Min Byun, Ja, et al.
Publicado: (2023)

Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma
por: Park, Songyi, et al.
Publicado: (2021)

Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation
por: Park, Woochan, et al.
Publicado: (2023)

Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
por: Byun, Ja Min, et al.
Publicado: (2018)

Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high‐risk multiple myeloma in Asian patients
por: Byun, Ja Min, et al.
Publicado: (2018)

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
por: Kyung, Sun Young, et al.
Publicado: (2018)

Epithelial-mesenchymal transition in keloid tissue
por: Yang, Chae-Eun, et al.
Publicado: (2018)

Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition
por: Gupta, Shiv K, et al.
Publicado: (2012)

PGC1α Loss Promotes Lung Cancer Metastasis through Epithelial-Mesenchymal Transition
por: Oh, Taek-In, et al.
Publicado: (2021)

Revealing Genomic Profile That Underlies Tropism of Myeloma Cells Using Whole Exome Sequencing
por: Koh, Youngil, et al.
Publicado: (2015)

Expression dynamics of integrin α2, α3, and αV upon osteogenic differentiation of human mesenchymal stem cells
por: Lee, Hyun Min, et al.
Publicado: (2020)

Concomitant ruxolitinib with cytarabine-based induction chemotherapy in secondary acute myeloid leukemia evolving from myeloproliferative neoplasm
por: Kim, Dong Hyun, et al.
Publicado: (2023)

Periostin induces epithelial-to-mesenchymal transition via the integrin α5β1/TWIST-2 axis in cholangiocarcinoma
por: Sonongbua, Jumaporn, et al.
Publicado: (2020)

Advantage of achieving deep response following frontline daratumumab-VTd compared to VRd in transplant-eligible multiple myeloma: multicenter study
por: Byun, Ja Min, et al.
Publicado: (2023)

P849: DEVELOPMENT OF A QUANTITATIVE ASSAY FOR ASSESSING BCL2’S PPI COMPLEXES AND ITS APPLICATION AS A TARGET ENGAGEMENT ASSAY IN CLINICAL SPECIMENS WITH MULTIPLE MYELOMA
por: Lee, Hongwon, et al.
Publicado: (2023)

P976: REAL-WORLD OUTCOMES OF PATIENTS WITH PENTA-EXPOSED MULTIPLE MYELOMA WHO WERE TREATED WITH SELINEXOR AND DEXAMETHASONE: KOREAN MULTICENTER RETROSPECTIVE ANALYSIS
por: Ho Yi, Jun, et al.
Publicado: (2023)

Distinctive patterns of peripheral neuropathy across the spectrum of plasma cell disorders
por: Byun, Ja Min, et al.
Publicado: (2019)

Integrin α5/ITGA5 Promotes The Proliferation, Migration, Invasion And Progression Of Oral Squamous Carcinoma By Epithelial–Mesenchymal Transition
por: Deng, Yun, et al.
Publicado: (2019)

Hypoxia Induces Epithelial-Mesenchymal Transition in Follicular Thyroid Cancer: Involvement of Regulation of Twist by Hypoxia Inducible Factor-1α
por: Yang, Yeon Ju, et al.
Publicado: (2015)

Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3
por: Petpiroon, Nareerat, et al.
Publicado: (2017)

Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma
por: Chen, Jiang, et al.
Publicado: (2019)

Induction of Apoptosis and Inhibition of Epithelial Mesenchymal Transition by α-Mangostin in MG-63 Cell Lines
por: Park, Sung-Jin, et al.
Publicado: (2018)

The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling
por: Lee, Jaeseob, et al.
Publicado: (2016)

P894: A PHASE II TRIAL TO EVALUATE THE EFFICACY OF DARATUMUMAB WITH DCEP IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER BORTEZOMIB BASED TREATMENT
por: Byun, J. M., et al.
Publicado: (2022)

Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin
por: Seo, Jeongmin, et al.
Publicado: (2021)

Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM
por: Park, Hyunkyung, et al.
Publicado: (2022)

Clinicopathological characteristics of extremely young Korean multiple myeloma patients: therapeutic implications
por: Shin, Junghoon, et al.
Publicado: (2017)

Correction: Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3
por: Petpiroon, Nareerat, et al.
Publicado: (2023)

Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
por: Nam, Chang Hyun, et al.
Publicado: (2021)

Serum Erythropoietin level in anemia of elderly with unclear etiology
por: Seong, Ju Yong, et al.
Publicado: (2023)

Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party
por: Kim, Seok Jin, et al.
Publicado: (2016)

Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration
por: Liu, Jun, et al.
Publicado: (2020)

Effect of aldosterone on epithelial-to-mesenchymal transition of human peritoneal mesothelial cells
por: Yu, Mina, et al.
Publicado: (2015)

Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis
por: Kim, Dong Hyun, et al.
Publicado: (2022)

Author Correction: Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma
por: Chen, Jiang, et al.
Publicado: (2019)

EDIL3 promotes epithelial–mesenchymal transition and paclitaxel resistance through its interaction with integrin α(V)β(3) in cancer cells
por: Gasca, J., et al.
Publicado: (2020)

Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea
por: Kim, Hyo Jung, et al.
Publicado: (2015)

Chemotherapy delivery time affects treatment outcomes of female patients with diffuse large B cell lymphoma
por: Kim, Dae Wook, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v0d4h9s78j4qm4gqtpmk4uphig